The effect of human immunodeficiency virus infection on adverse events during treatment of drug-resistant tuberculosis: A systematic review and meta-analysis.
Gilbert LazarusKevin TjoaAnthony William Brian IskandarMelva LouisaEvans L SagwaNesri PadayacthiVivian SoetiknoPublished in: PloS one (2021)
HIV co-infection independently increased the risk of developing AEs during DR-TB treatment. Increased pharmacovigilance through routine assessments of audiological, renal, and mental functions are strongly encouraged to enable prompt diagnosis and treatment in patients experiencing AEs during concomitant DR-TB and HIV treatment.
Keyphrases
- human immunodeficiency virus
- antiretroviral therapy
- drug resistant
- hepatitis c virus
- hiv infected
- hiv aids
- hiv positive
- mycobacterium tuberculosis
- multidrug resistant
- hiv testing
- acinetobacter baumannii
- mental health
- emergency department
- men who have sex with men
- clinical practice
- replacement therapy
- combination therapy
- editorial comment
- pseudomonas aeruginosa
- electronic health record
- pulmonary tuberculosis